Susquehanna International Group’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.07M | Buy |
97,000
+8,500
| +10% | +$510K | ﹤0.01% | 4196 |
|
|
2025
Q4 | $5.2M | Buy |
88,500
+73,900
| +506% | +$4.49M | ﹤0.01% | 3951 |
|
|
2025
Q3 | $812K | Sell |
14,600
-24,400
| -63% | -$1.31M | ﹤0.01% | 7835 |
|
|
2025
Q2 | $2.01M | Buy |
39,000
+22,200
| +132% | +$1.12M | ﹤0.01% | 5769 |
|
|
2025
Q1 | $985K | Sell |
16,800
-88,300
| -84% | -$5.98M | ﹤0.01% | 7300 |
|
|
2024
Q4 | $7.57M | Buy |
105,100
+86,900
| +477% | +$6.38M | ﹤0.01% | 2997 |
|
|
2024
Q3 | $1.45M | Sell |
18,200
-26,600
| -59% | -$2M | ﹤0.01% | 5983 |
|
|
2024
Q2 | $3.21M | Buy |
44,800
+15,600
| +53% | +$1.15M | ﹤0.01% | 4190 |
|
|
2024
Q1 | $2.06M | Sell |
29,200
-54,400
| -65% | -$3.89M | ﹤0.01% | 5268 |
|
|
2023
Q4 | $6.45M | Buy |
83,600
+12,400
| +17% | +$817K | ﹤0.01% | 3292 |
|
|
2023
Q3 | $4.85M | Sell |
71,200
-78,200
| -52% | -$6.18M | ﹤0.01% | 3587 |
|
|
2023
Q2 | $12.2M | Buy |
149,400
+68,400
| +84% | +$5.5M | ﹤0.01% | 2274 |
|
|
2023
Q1 | $6.01M | Buy |
81,000
+29,500
| +57% | +$2.27M | ﹤0.01% | 3171 |
|
|
2022
Q4 | $4.27M | Sell |
51,500
-53,300
| -51% | -$4.23M | ﹤0.01% | 3475 |
|
|
2022
Q3 | $7.44M | Buy |
104,800
+73,600
| +236% | +$6.36M | ﹤0.01% | 2568 |
|
|
2022
Q2 | $2.7M | Sell |
31,200
-30,400
| -49% | -$2.85M | ﹤0.01% | 4269 |
|
|
2022
Q1 | $6.67M | Sell |
61,600
-28,000
| -31% | -$2.89M | ﹤0.01% | 3162 |
|
|
2021
Q4 | $11.6M | Buy |
89,600
+28,800
| +47% | +$3.53M | ﹤0.01% | 2518 |
|
|
2021
Q3 | $7.37M | Sell |
60,800
-70,800
| -54% | -$8.62M | ﹤0.01% | 3320 |
|
|
2021
Q2 | $14.8M | Buy |
131,600
+110,800
| +533% | +$11.7M | ﹤0.01% | 2385 |
|
|
2021
Q1 | $1.99M | Buy |
20,800
+9,600
| +86% | +$876K | ﹤0.01% | 5939 |
|
|
2020
Q4 | $889K | Sell |
11,200
-90,000
| -89% | -$6.52M | ﹤0.01% | 6985 |
|
|
2020
Q3 | $6.27M | Sell |
101,200
-88,000
| -47% | -$5.72M | ﹤0.01% | 2777 |
|
|
2020
Q2 | $12.5M | Buy |
189,200
+35,600
| +23% | +$2.13M | ﹤0.01% | 1893 |
|
|
2020
Q1 | $7.28M | Buy |
153,600
+135,200
| +735% | +$6.76M | ﹤0.01% | 2114 |
|
|
2019
Q4 | $1.01M | Buy |
18,400
+11,200
| +156% | +$588K | ﹤0.01% | 5504 |
|
|
2019
Q3 | $352K | Sell |
7,200
-400
| -5% | -$20.1K | ﹤0.01% | 7973 |
|
|
2019
Q2 | $396K | Sell |
7,600
-800
| -10% | -$40.3K | ﹤0.01% | 7758 |
|
|
2019
Q1 | $417K | Buy |
8,400
+400
| +5% | +$18K | ﹤0.01% | 6619 |
|
|
2018
Q4 | $289K | Buy |
8,000
+800
| +11% | +$33.4K | ﹤0.01% | 7077 |
|
|
2018
Q3 | $367K | Sell |
7,200
-9,200
| -56% | -$408K | ﹤0.01% | 7078 |
|
|
2018
Q2 | $607K | Sell |
16,400
-14,000
| -46% | -$535K | ﹤0.01% | 6403 |
|
|
2018
Q1 | $1.15M | Buy |
30,400
+20,800
| +217% | +$735K | ﹤0.01% | 4967 |
|
|
2017
Q4 | $311K | Sell |
9,600
-21,200
| -69% | -$674K | ﹤0.01% | 7539 |
|
|
2017
Q3 | $931K | Sell |
30,800
-21,600
| -41% | -$641K | ﹤0.01% | 5406 |
|
|
2017
Q2 | $1.54M | Buy |
52,400
+23,600
| +82% | +$645K | ﹤0.01% | 4385 |
|
|
2017
Q1 | $732K | Buy |
+28,800
| New | +$743K | ﹤0.01% | 5771 |
|
|
2016
Q3 | – | Sell |
-8,000
| Closed | -$226K | – | 9037 |
|
|
2016
Q2 | $226K | Buy |
+8,000
| New | +$206K | ﹤0.01% | 7405 |
|
|
2015
Q4 | – | Sell |
-13,200
| Closed | -$305K | – | 9969 |
|
|
2015
Q3 | $305K | Buy |
13,200
+4,400
| +50% | +$110K | ﹤0.01% | 8016 |
|
|
2015
Q2 | $217K | Buy |
+8,800
| New | +$220K | ﹤0.01% | 9155 |
|
Other funds holding TECH
VCM
VPM
MC
Susquehanna International Group's TECH Position: Q1 2026 in Review
Susquehanna International Group reduced its Bio-Techne (TECH) stake by 40% in Q1 2026, selling an estimated $1.43M and leaving 36,129 shares worth $1.89M. The position accounts for ﹤0.01% of the portfolio, ranked #6315.
Susquehanna International Group first reported a position in TECH in Q2 2013 and has held it in 40 quarters since. The position peaked at $9.82M in Q4 2021. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.
- Susquehanna International Group held 36,129 shares of Bio-Techne worth $1.89M as of Q1 2026.
- Susquehanna International Group sold 23,789 Bio-Techne shares in Q1 2026, an estimated $1.43M.
- Bio-Techne made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #6315 holding.
- Susquehanna International Group first reported a position in Bio-Techne in Q2 2013 and has held it in 40 quarters since.
- Susquehanna International Group's Bio-Techne position peaked at $9.82M in Q4 2021.
- 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.